Insmed (INSM) Depreciation & Amortization (CF) (2010 - 2026)

Insmed's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 55.82% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $11.5 million, a 81.91% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, up 73.33% from the prior year.
• Depreciation & Amortization (CF) fell to $2.9 million in Q1 2026 per INSM's latest filing, from $3.6 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $3.6 million in Q4 2025 and bottomed at $851000.0 in Q3 2022.
• The 5-year median for Depreciation & Amortization (CF) is $1.5 million (2023), against an average of $1.8 million.
• Across the five-year window, Depreciation & Amortization (CF) slumped 61.97% in 2022 and jumped 135.66% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $2.2 million in 2022, then slumped by 32.43% to $1.5 million in 2023, then grew by 2.85% to $1.5 million in 2024, then soared by 135.66% to $3.6 million in 2025, then dropped by 17.93% to $2.9 million in 2026.
• Per Business Quant, the three latest INSM Depreciation & Amortization (CF) figures stand at $2.9 million (Q1 2026), $3.6 million (Q4 2025), and $2.5 million (Q3 2025).